You are here

COVID-19

Main US COVID markers mixed bag; main ones show slight rise, two indicate decline

US COVID-19 hospitalizations and deaths continued their slow rise over the past week, but two early indicators showed declines, the Centers for Disease Control and Prevention (CDC) said in its latest data update.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations -- studies

Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to COVID-19
howdy folks
Page loaded in 1.313 seconds.